ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACAD
1
OrderDrugGeneLife-limiting?US est. PopakaCompanyINDDoseApprovalRouteUS Age/SexLinkPhaseOther
2
1ZolgensmaSMN1YesSMA all typesNovartis (Avexis)6/23/20177/20/20175/24/2019IV
3
2ZyntegloSMN1YesSMA t2 and t3Bluebird/Spark6/26/201810/31/20185/27/2022IT
4
3UpstazaDDCNo??AADC DeficiencyPTC Therapeutics7/18/2022 (EMA)Putamen18 months+
https://aadcnews.com/ptc-aadc/
5
4PBGM01GLB1Yes
GM1 Gangliosidosis
Passage Bio1/4/2021Not yetICM
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study
1/2
6
5NGN-101CLN5YesTinyBattenNeurogene9/1/20211/1/2022Not Yetintracisternal
https://www.cgtlive.com/view/neurogene-clinical-trial-seeks-assess-cln5-batten-disease-gene-therapy-ngn-101
1/2
7
6MelpidaAP4M1YesTinySPG5012/30/213/24/2022Not YetIT
https://toronto.ctvnews.ca/toronto-boy-with-rare-genetic-disorder-begins-treatment-after-family-raises-us-3-million-1.6027732
Canada
8
7TSHA-102MECP2No30,000 per JagRettTaysha8/14/231/10/2024Not yetIT3-8 Females
https://ir.tayshagtx.com/node/9036/pdf
1/2
Axovant Gene Therapies, Biogen, and Voyager Therapeutics
9
8GS-100NGLY1MaybeTinyGrace Science11/7/23Not yetICV2-18 both
https://www.biospace.com/article/releases/grace-science-announces-fda-clearance-of-investigational-new-drug-ind-application-to-initiate-a-phase-1-2-3-trial-for-the-treatment-of-ngly1-deficiency-with-gs-100-an-aav9-ngly1-gene-therapy/
1/2/3
10
9JAG201SHANK3No?PMSJaguar1/31/242H24Not yetICVAdults both
https://pmsf.org/breaking-news-from-jaguar-gene-therapy/
1
11
10ETX101SCN1AYes?DravetEncoded2/6/241H24Not yet
0-3 (US) 3-7 (Aus)
https://encoded.com/press-releases/encoded-therapeutics-announces-us-ind-clearance-and-australian-cta-approval-for-dravet-syndrome-gene-therapy-candidate-etx101/
1/2
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100